Diagnosis of Pulmonary and Extrapulmonary Tuberculosis

Tuberculosis: Fourth Edition: The Essentials

Volumn , Issue , 2016, Pages 81-112

  Lam, Phung K ^a   Catanzaro, Antonino ^a   Perry, Sharon ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855772604     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420090239-7     Document Type: Chapter

References (185)

1. Schluger NW. The diagnosis of tuberculosis: what’s old, what’s new. Semin Respir Infect 2003; 18(4):241-248.
2. Arango L, Brewin AW, Murray JF. The spectrum of tuberculosis as currently seen in a metropolitan hospital. Am Rev Respir Dis 1973; 108(4):805-812.
3. MacGregor RR. A year’s experience with tuberculosis in a private urban teaching hospital in the postsanatorium era. Am J Med 1975; 58(2):221-228.
4. Friedman LN, Selwyn PA. Pulmonary tuberculosis: primary, reactivation, HIV related, and non-HIV related. In: Friedman LN, ed. Tuberculosis: Current Concepts and Treatment. Boca Raton, FL: CRC Press, 1994.
5. Samb B, Henzel D, Daley CL, et al. Methods for diagnosing tuberculosis among in-patients in eastern Africa whose sputum smears are negative. Int J Tuberc Lung Dis 1997; 1(1):25-30.
6. Hopewell PC. A clinical view of tuberculosis. Radiol Clin North Am 1995; 33(4):641-653.
7. Murray HW, Tuazon CU, Kirmani N, et al. The adult respiratory distress syndrome associated with miliary tuberculosis. Chest 1978; 73(1):37-43.
8. Catanzaro A, Perry S, Clarridge JE, et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA 2000; 283(5):639-645.
9. Cameron SJ. Tuberculosis and the blood-a special relationship? Tubercle 1974; 55(1): 55-72.
10. Abbasi AA, Chemplavil JK, Farah S, et al. Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med 1979; 90(3):324-328.
11. Chung DK, Hubbard WW. Hyponatremia in untreated active pulmonary tuberculosis. Am Rev Respir Dis 1969; 99(4):595-597.
12. Christie JD, Callihan DR. The laboratory diagnosis of mycobacterial diseases. Challenges and common sense. Clin Lab Med 1995; 15(2):279-306.
13. Fishman JA, Roth RS, Zanzot E, et al. Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii. J Clin Microbiol 1994; 32(1):131-134.
14. Jensen PA, Lambert LA, Iademarco MF, et al. CDC. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR Recomm Rep 2005; 54(RR-17); 1-141.
15. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167(4):603-662.
16. Baughman RP, Dohn MN, Loudon RG, et al. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest 1991; 99(1):92-97.
17. Wallace JM, Deutsch AL, Harrell JH, et al. Bronchoscopy and transbronchial biopsy in evaluation of patients with suspected active tuberculosis. Am JMed 1981; 70(6):1189-1194.
18. Conde MB, Soares SL, Mello FC, et al. Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: Experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. Am J Respir Crit Care Med 2000; 162(6):2238-2240.
19. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161(4 Pt 1):1376-1395.
20. Daniel TM. Rapid diagnosis of tuberculosis: Laboratory techniques applicable in developing countries. Rev Infect Dis 1989; 11(suppl 2):S471-S478.
21. Greenbaum M, Beyt BE Jr, Murray PR. The accuracy of diagnosing pulmonary tuberculosis at a teaching hospital. Am Rev Respir Dis 1980; 121(3):477-481.
22. Levy H, Feldman C, Sacho H, et al. A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989; 95(6):1193-1197.
23. Long R, Scalcini M, Manfreda J, et al. The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis. Am J Public Health 1991; 81(10):1326-1328.
24. Yajko DM, Nassos PS, Sanders CA, et al. High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens. Clin Infect Dis 1994; 19(2):334-336.
25. Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6(9):570-581.
26. Hung NV, Sy DN, Anthony RM, et al. Fluorescence microscopy for tuberculosis diagnosis. Lancet Infect Dis 2007; 7(4):238-239.
27. Sohn H, Sinthuwattanawibool C, Rienthong S, et al. Fluorescence microscopy is less expensive than Ziehl-Neelsen microscopy in Thailand. Int J Tuberc Lung Dis 2009; 13(2):266-268.
28. Kivihya-Ndugga LE, van Cleeff MR, Githui WA, et al. A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resourcepoor urban setting. Int J Tuberc Lung Dis 2003; 7(12):1163-1171.
29. Cruciani M, Scarparo C, Malena M, et al. Meta-analysis ofBACTECMGIT960 andBACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 2004; 42(5):2321-2325.
30. Moore DAJ, Evans CAW, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355(15):1539-1550.
31. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340(5):367-373.
32. Talavera W, Lessnau KK, Handwerger S. Extrapulmonary tuberculosis. In: Friedman LN, ed. Tuberculosis: Current Concepts and Treatment. Boca Raton, FL: CRC Press, 1994:113-151.
33. Thornton GF. Extrapulmonary tuberculosis, excluding the central nervous system. In: Rossman MD, MacGregor RR, eds. Tuberculosis: Clinical Management and New Challenges. New York: McGraw Hill, 1995:173-184.
34. Christensen WI. Genitourinary tuberculosis: Review of 102 cases. Medicine (Baltimore) 1974; 53(5):377-390.
35. Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol 1993; 88(7):989-999.
36. Ribera E, Ocana I, Martinez-Vazquez JM, et al. High level of interferon gamma in tuberculous pleural effusion. Chest 1988; 93(2):308-311.
37. Valdes L, San Jose E, Alvarez D, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993; 103(2): 458-465.
38. McAdams HP, Erasmus J, Winter JA. Radiologic manifestations of pulmonary tuberculosis. Radiol Clin North Am 1995; 33(4):655-678.
39. Palmer PE. Pulmonary tuberculosis-usual and unusual radiographic presentations. Semin Roentgenol 1979; 14(3):204-243.
40. Leung AN, Muller NL, Pineda PR, et al. Primary tuberculosis in childhood: radiographic manifestations. Radiology 1992; 182(1):87-91.
41. Miller WT, Miller WT Jr. Tuberculosis in the normal host: Radiological findings. Semin Roentgenol 1993; 28(2):109-118.
42. Woodring JH, Vandiviere HM, Fried AM, et al. Update: the radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol 1986; 146(3):497-506.
43. Lintin SN, Isaac PA. Miliary tuberculosis presenting as adult respiratory distress syndrome. Intensive Care Med 1988; 14(6):672-674.
44. Greenberg SD, Frager D, Suster B, et al. Active pulmonary tuberculosis in patients with AIDS: Spectrum of radiographic findings (including a normal appearance). Radiology 1994; 193(1):115-119.
45. Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985; 131(3):393-396.
46. Miller WT. Expanding options for the radiographic evaluation of tuberculosis. In: Rossman MD, MacGregor RR, eds. Tuberculosis: Clinical Management and New Challenges. New York: McGraw Hill, 1995:275-289.
47. Clarridge JE III, Shawar RM, Shinnick TM, et al. Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol 1993; 31(8):2049-2056.
48. Eisenach KD, Sifford MD, Cave MD, et al. Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis 1991; 144(5): 1160-1163.
49. Woods GL. The mycobacteriology laboratory and new diagnostic techniques. Infect Dis Clin North Am 2002; 16(1):127-144.
50. Mathur P, Sacks L, Auten G, et al. Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med 1994; 154(3):306-310.
51. Alcala L, Ruiz-Serrano MJ, Hernangomez S, et al. Evaluation of the upgraded amplified Mycobacterium tuberculosis direct test (gen-probe) for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn Microbiol Infect Dis 2001; 41(1-2):51-56.
52. Bergmann JS, Woods GL. Enhanced Amplified Mycobacterium Tuberculosis Direct Test for detection of Mycobacterium tuberculosis complex in positive BACTEC 12B broth cultures of respiratory specimens. J Clin Microbiol 1999; 37(6):2099-2101.
53. Bodmer T, Mockl E, Muhlemann K, et al. Improved performance of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test when 500 instead of 50 microliters of decontaminated sediment is used. J Clin Microbiol 1996; 34(1):222-223.
54. Chedore P, Jamieson FB. Routine use of the Gen-Probe MTD2 amplification test for detection of Mycobacterium tuberculosis in clinical specimens in a large public health mycobacteriology laboratory. Diagn Microbiol Infect Dis 1999; 35(3):185-191.
55. Coll P, Garrigo M, Moreno C, et al. Routine use of Gen-Probe Amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis with smear-positive and smear-negative specimens. Int J Tuberc Lung Dis 2003; 7(9): 886-891.
56. Gamboa F, Fernandez G, Padilla E, et al. Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 1998; 36(3):684-689.
57. Jonas V, Alden MJ, Curry JI, et al. Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol 1993; 31(9):2410-2416.
58. O’Sullivan CE, Miller DR, Schneider PS, et al. Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J Clin Microbiol 2002; 40(5):1723-1727.
59. Smith MB, Bergmann JS, Onoroto M, et al. Evaluation of the enhanced amplified Mycobacterium tuberculosis direct test for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. Arch Pathol Lab Med 1999; 123(11):1101-1103.
60. Carpentier E, Drouillard B, Dailloux M, et al. Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: A multicenter study. J Clin Microbiol 1995; 33(12): 3106-3110.
61. Cartuyvels R, De Ridder C, Jonckheere S, et al. Prospective clinical evaluation of Amplicor Mycobacterium tuberculosis PCR test as a screening method in a low-prevalence population. J Clin Microbiol 1996; 34(8):2001-2003.
62. Rajalahti I, Vuorinen P, Nieminen MM, et al. Detection of Mycobacterium tuberculosis complex in sputum specimens by the automated Roche Cobas Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol 1998; 36(4):975-978.
63. Reischl U, Lehn N, Wolf H, et al. Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol 1998; 36(10):2853-2860.
64. Shah JS, Liu J, Buxton D, et al. Detection of Mycobacterium tuberculosis directly from spiked human sputum by Q-beta replicase-amplified assay. J Clin Microbiol 1995; 33(2): 322-328.
65. Bergmann JS, Keating WE, Woods GL. Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis. J Clin Microbiol 2000; 38(2):863-865.
66. Little MC, Andrews J, Moore R, et al. Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem 1999; 45(6 Pt 1):777-784.
67. Mazzarelli G, Rindi L, Piccoli P, et al. Evaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study. J Clin Microbiol 2003; 41(4):1779-1782.
68. Boehme CC, Nabeta P, Henostroza G, et al. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 2007; 45(6):1936-1940.
69. Centers for Disease Control and Prevention (CDC). Update: Nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 2000; 49(26):593-594.
70. Cloud JL, Shutt C, Aldous W, et al. Evaluation of a Modified Gen-Probe Amplified Direct Test for Detection of Mycobacterium tuberculosis complex organisms in cerebrospinal fluid. J Clin Microbiol 2004; 42(11):5341-5344.
71. D’Amato RF, Hochstein LH, Colaninno PM, et al. Application of the Roche Amplicor Mycobacterium tuberculosis (PCR) test to specimens other than respiratory secretions. Diagn Microbiol Infect Dis 1996; 24(1):15-17.
72. Ehlers S, Ignatius R, Regnath T, et al. Diagnosis of extrapulmonary tuberculosis by Gen-Probe amplified Mycobacterium tuberculosis direct test. J Clin Microbiol 1996; 34(9):2275-2279.
73. Gamboa F, Dominguez J, Padilla E, et al. Rapid diagnosis of extrapulmonary tuberculosis by ligase chain reaction amplification. J Clin Microbiol 1998; 36(5):1324-1329.
74. Portillo-Gomez L, Morris SL, Panduro A. Rapid and efficient detection of extra-pulmonary Mycobacterium tuberculosis by PCR analysis. Int J Tuberc Lung Dis 2000; 4(4):361-370.
75. Rajo MC, Perez Del Molina ML, Lado Lado FL, et al. Rapid diagnosis of tuberculous meningitis by ligase chain reaction amplification. Scand J Infect Dis 2002; 34(1):14-16.
76. Rantakokko-Jalava K, Marjamaki M, Marttila H, et al. LCx Mycobacterium tuberculosis assay is valuable with respiratory specimens, but provides little help in the diagnosis of extrapulmonary tuberculosis. Ann Med 2001; 33(1):55-62.
77. Woods GL, Bergmann JS, Williams-Bouyer N. Clinical Evaluation of the Gen-Probe amplified Mycobacterium tuberculosis direct test for rapid detection of Mycobacterium tuberculosis in select nonrespiratory specimens. J Clin Microbiol 2001; 39(2):747-749.
78. Daley P, Thomas S, Pai M. Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: A systematic review. Int J Tuberc Lung Dis 2007; 11(11):1166-1176.
79. Pai M, Flores LL, Hubbard A, et al. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: A systematic review and meta-analysis. BMC Infect Dis 2004; 4:6.
80. Pai M, Flores LL, Pai N, et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003; 3(10):633-643.
81. Ling DI, Flores LL, Riley LW, et al. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: Meta-analysis and meta-regression. PLoS One 2008; 3(2):e1536.
82. Lebrun L, Mathieu D, Saulnier C, et al. Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis. Eur Respir J 1997; 10(8):1874-1876.
83. Sarmiento OL, Weigle KA, Alexander J, et al. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J Clin Microbiol 2003; 41(7):3233-3240.
84. Barnes PF, Lakey DL, Burman WJ. Tuberculosis in patients with HIV infection. Infect Dis Clin North Am 2002; 16(1):107-126.
85. Perry S, Catanzaro A. Use of clinical risk assessments in evaluation of nucleic acid amplification tests for HIV/tuberculosis. Int J Tuberc Lung Dis 2000; 4(2)(suppl 1):S34-S40.
86. Delacourt C, Poveda JD, Chureau C, et al. Use of polymerase chain reaction for improved diagnosis of tuberculosis in children. J Pediatr 1995; 126(5 Pt 1):703-709.
87. Pierre C, Olivier C, Lecossier D, et al. Diagnosis of primary tuberculosis in children by amplification and detection of mycobacterial DNA. Am Rev Respir Dis 1993; 147(2): 420-424.
88. Condos R, McClune A, Rom WN, et al. Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis. Lancet 1996; 347(9008):1082-1085.
89. Folgueira L, Delgado R, Palenque E, et al. Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR. J Clin Microbiol 1996; 34(3):512-515.
90. Richter C, Kox LF, Van Leeuwen JV, et al. PCR detection of mycobacteraemia in Tanzanian patients with extrapulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 1996; 15(10): 813-817.
91. Ritis K, Tzoanopoulos D, Speletas M, et al. Amplification of IS6110 sequence for detection of Mycobacterium tuberculosis complex in HIV-negative patients with fever of unknown origin (FUO) and evidence of extrapulmonary disease. J Intern Med 2000; 248(5):415-424.
92. Rolfs A, Beige J, Finckh U, et al. Amplification of Mycobacterium tuberculosis from peripheral blood. J Clin Microbiol 1995; 33(12):3312-3314.
93. Schluger NW, Condos R, Lewis S, et al. Amplification ofDNAof Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet 1994; 344(8917): 232-233.
94. Hadgu A, Sternberg M. Nucleic acid amplification tests for diagnosis of tuberculous meningitis. Lancet Infect Dis 2004; 4(1):9-10.
95. Kox LF, Kuijper S, Kolk AH. Early diagnosis of tuberculous meningitis by polymerase chain reaction. Neurology 1995; 45(12):2228-2232.
96. Pfyffer GE, Kissling P, Jahn EM, et al. Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol 1996; 34(4):834-841.
97. Fontana D, Pozzi E, Porpiglia F, et al. Rapid identification of Mycobacterium tuberculosis complex on urine samples by Gen-Probe amplification test. Urol Res 1997; 25(6): 391-394.
98. Sechi LA, Pinna MP, Sanna A, et al. Detection of Mycobacterium tuberculosis by PCR analysis of urine and other clinical samples from AIDS and non-HIV-infected patients. Mol Cell Probes 1997; 11(4):281-285.
99. Mitarai S, Shishido H, Kurashima A, et al. Comparative study of amplicor Mycobacterium PCR and conventional methods for the diagnosis of pleuritis caused by mycobacterial infection. Int J Tuberc Lung Dis 2000; 4(9):871-876.
100. Nagesh BS, Sehgal S, Jindal SK, et al. Evaluation of polymerase chain reaction for detection of Mycobacterium tuberculosis in pleural fluid. Chest 2001; 119(6):1737-1741.
101. Villena V, Rebollo MJ, Aguado JM, et al. Polymerase chain reaction for the diagnosis of pleural tuberculosis in immunocompromised and immunocompetent patients. Clin Infect Dis 1998; 26(1):212-214.
102. Smith KC, Starke JR, Eisenach K, et al. Detection of Mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction. Pediatrics 1996; 97(2): 155-160.
103. Johansen IS, Lundgren B, Tabak F, et al. Improved sensitivity of nucleic acid amplification for rapid diagnosis of tuberculous meningitis. J Clin Microbiol 2004; 42(7):3036-3040.
104. Al Zahrani K, Al Jahdali H, Poirier L, et al. Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis. Am J Respir Crit Care Med 2000; 162(4 Pt 1):1323-1329.
105. Piersimoni C, Scarparo C, Piccoli P, et al. Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens. J Clin Microbiol 2002; 40(11):4138-4142.
106. Sloutsky A, Han LL, Werner BG. Practical strategies for performance optimization of the enhanced gen-probe amplified Mycobacterium tuberculosis direct test. J Clin Microbiol 2004; 42(4):1547-1551.
107. Kerleguer A, Koeck JL, Fabre M, et al. Use of equivocal zone in interpretation of results of the amplified Mycobacterium tuberculosis direct test for diagnosis of tuberculosis. J Clin Microbiol 2003; 41(4):1783-1784.
108. Middleton AM, Cullinan P, Wilson R, et al. Interpreting the results of the amplified Mycobacterium tuberculosis direct test for detection of M. tuberculosis rRNA. J Clin Microbiol 2003; 41(6):2741-2743.
109. Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med 1997; 155(5):1804-1814.
110. Chin DP, Yajko DM, Hadley WK, et al. Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med 1995; 151(6):1872-1877.
111. Cohen RA, Muzaffar S, Schwartz D, et al. Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am J Respir Crit Care Med 1998; 157(1):156-161.
112. Lim TK, Mukhopadhyay A, Gough A, et al. Role of clinical judgment in the application of a nucleic acid amplification test for the rapid diagnosis of pulmonary tuberculosis. Chest 2003; 124(3):902-908.
113. Schluger NW, Rom WN. The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections. Am J Respir Crit Care Med 1995; 152(1):11-16.
114. Lim TK, Gough A, Chin NK, et al. Relationship between estimated pretest probability and accuracy of automated Mycobacterium tuberculosis assay in smear-negative pulmonary tuberculosis. Chest 2000; 118(3):641-647.
115. Wisnivesky JP, Kaplan J, Henschke C, et al. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med 2000; 160(16):2471-2476.
116. Della-Latta P, Whittier S. Comprehensive evaluation of performance, laboratory application, and clinical usefulness of two direct amplification technologies for the detection of Mycobacterium tuberculosis complex. Am J Clin Pathol 1998; 110(3):301-310.
117. Gamboa F, Manterola JM, Lonca J, et al. Comparative evaluation of two commercial assays for direct detection of Mycobacterium tuberculosis in respiratory specimens. Eur J Clin Microbiol Infect Dis 1998; 17(3):151-157.
118. Ichiyama S, Iinuma Y, Tawada Y, et al. Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche PCR-microwell plate hybridization method (AMPLICOR MYCOBACTERIUM) for direct detection of mycobacteria. J Clin Microbiol 1996; 34(1):130-133.
119. Scarparo C, Piccoli P, Rigon A, et al. Comparison of enhanced Mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol 2000; 38(4):1559-1562.
120. Visca P, De Mori P, Festa A, et al. Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis. Clin Microbiol Infect 2004; 10(4):332-334.
121. Iinuma Y, Senda K, Fujihara N, et al. Comparison of the BDProbeTec ET system with the Cobas Amplicor PCR for direct detection of Mycobacterium tuberculosis in respiratory samples. Eur J Clin Microbiol Infect Dis 2003; 22(6):368-371.
122. Burkardt HJ. Standardization and quality control of PCR analyses. Clin Chem Lab Med 2000; 38(2):87-91.
123. Noordhoek GT, van Embden JD, Kolk AH. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol 1996; 34(10):2522-2525.
124. Noordhoek GT, Mulder S, Wallace P, et al. Multicentre quality control study for detection of Mycobacterium tuberculosis in clinical samples by nucleic amplification methods. Clin Microbiol Infect 2004; 10(4):295-301.
125. Ridderhof JC, Williams LO, Legois S, et al. Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis. J Clin Microbiol 2003; 41(11):5258-5261.
126. Doern GV. Diagnostic mycobacteriology: Where are we today? J Clin Microbiol 1996; 34(8):1873-1876.
127. Dowdy DW, Maters A, Parrish N, et al. Cost-effectiveness analysis of the gen-probe amplified Mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol 2003; 41(3):948-953.
128. Lim TK, Cherian J, Poh KL, et al. The rapid diagnosis of smear-negative pulmonary tuberculosis: A cost-effectiveness analysis. Respirology 2000; 5(4):403-409.
129. Kambashi B, Mbulo G, McNerney R, et al. Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis 2001; 5(4):364-369.
130. Roos BR, van Cleeff MR, Githui WA, et al. Cost-effectiveness of the polymerase chain reaction versus smear examination for the diagnosis of tuberculosis in Kenya: A theoretical model. Int J Tuberc Lung Dis 1998; 2(3):235-241.
131. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrugresistant tuberculosis: A meta-analysis. Eur Respir J 2008; 32(5):1165-1174.
132. Morgan M, Kalantri S, Flores L, et al. Acommercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis. BMC Infect Dis 2005; 5:62.
133. Hillemann D, Weizenegger M, Kubica T, et al. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43(8):3699-3703.
134. Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177(7):787-792.
135. World Health Organization Expert Group. Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis (MDR-TB): Policy Statement. February 3, 2009.
136. Garg SK, Tiwari RP, Tiwari D, et al. Diagnosis of tuberculosis: Available technologies, limitations, and possibilities. J Clin Lab Anal 2003; 17(5):155-163.
137. Laal S, Samanich KM, Sonnenberg MG, et al. Surrogate marker of preclinical tuberculosis in human immunodeficiency virus infection: Antibodies to an 88-kDa secreted antigen of Mycobacterium tuberculosis. J Infect Dis 1997; 176(1):133-143.
138. Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356(9235):1099-1104.
139. Lodha R, Kabra SK. Newer diagnostic modalities for tuberculosis. Indian J Pediatr 2004; 71(3):221-227.
140. Chan ED, Heifets L, Iseman MD. Immunologic diagnosis of tuberculosis: A review. Tuber Lung Dis 2000; 80(3):131-140.
141. Okuda Y, Maekura R, Hirotani A, et al. Rapid serodiagnosis of active pulmonary Mycobacterium tuberculosis by analysis of results from multiple antigen-specific tests. JClin Microbiol 2004; 42(3):1136-1141.
142. Silva VM, Kanaujia G, Gennaro ML, et al. Factors associated with humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of tuberculosis. Int J Tuberc Lung Dis 2003; 7(5):478-484.
143. Talbot EA, Hay B, Hone NM, et al. Tuberculosis serodiagnosis in a predominantly HIVinfected population of hospitalized patients with cough, Botswana, 2002. Clin Infect Dis 2004; 39(1):e1-e7.
144. Houghton RL, Lodes MJ, Dillon DC, et al. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin Diagn Lab Immunol 2002; 9(4):883-891.
145. Balestrino EA, Daniel TM, de Latini MD, et al. Serodiagnosis of pulmonary tuberculosis in Argentina by enzyme-linked immunosorbent assay (ELISA) of IgG antibody to Mycobacterium tuberculosis antigen 5 and tuberculin purified protein derivative. Bull World Health Organ 1984; 62(5):755-761.
146. Ma Y, Wang YM, Daniel TM. Enzyme-linked immunosorbent assay using Mycobacterium tuberculosis antigen 5 for the diagnosis of pulmonary tuberculosis in China. Am Rev Respir Dis 1986; 134(6):1273-1275.
147. Bothamley G, Beck JS, Britton W, et al. Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy. Clin Exp Immunol 1991; 86(3):426-432.
148. Sada E, Brennan PJ, Herrera T, et al. Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis. J Clin Microbiol 1990; 28(12):2587-2590.
149. Sada E, Ferguson LE, Daniel TM. An ELISA for the serodiagnosis of tuberculosis using a 30, 000-Da native antigen of Mycobacterium tuberculosis. J Infect Dis 1990; 162(4):928-931.
150. Uma Devi KR, Ramalingam B, Raja A. Antibody response to Mycobacterium tuberculosis 30 and 16kDa antigens in pulmonary tuberculosis with human immunodeficiency virus coinfection. Diagn Microbiol Infect Dis 2003; 46(3):205-209.
151. Munk ME, Arend SM, Brock I, et al. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis 2001; 183(1):175-176.
152. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002; 40(2):704-706.
153. Scarpellini P, Tasca S, Galli L, et al. Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection. J Clin Microbiol 2004; 42(8):3469-3474.
154. Bothamley GH, Rudd R, Festenstein F, et al. Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax 1992; 47(4): 270-275.
155. Steingart KR, Dendukuri N, Henry M, et al. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: A meta-analysis. Clin Vaccine Immunol 2009; 16(2):260-276.
156. Steingart KR, Henry M, Laal S, et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Postgrad Med J 2007; 83(985):705-712.
157. Kanaujia GV, Lam P, Perry S, et al. Integration of microscopy and serodiagnostic tests to screen for active tuberculosis. Int J Tuberc Lung Dis 2005; 9(10):1120-1126.
158. van Pinxteren LA, Ravn P, Agger EM, et al. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000; 7(2):155-160.
159. Pottumarthy S, Wells VC, Morris AJ. A comparison of seven tests for serological diagnosis of tuberculosis. J Clin Microbiol 2000; 38(6):2227-2231.
160. Perkins MD, Conde MB, Martins M, et al. Serologic diagnosis of tuberculosis using a simple commercial multiantigen assay. Chest 2003; 123(1):107-112.
161. Maekura R, Kohno H, Hirotani A, et al. Prospective clinical evaluation of the serologic tuberculous glycolipid test in combination with the nucleic acid amplification test. J Clin Microbiol 2003; 41(3):1322-1325.
162. Hamasur B, Bruchfeld J, Haile M, et al. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods 2001; 45(1):41-52.
163. Tessema TA, Bjune G, Assefa G, et al. Clinical and radiological features in relation to urinary excretion of lipoarabinomannan in Ethiopian tuberculosis patients. Scand J Infect Dis 2002; 34(3):167-171.
164. Boehme C, Molokova E, Minja F, et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005; 99(12):893-900.
165. Huebner RE, Schein MF, Bass JB, Jr. The tuberculin skin test. Clin Infect Dis 1993; 17(6): 968-975.
166. Canessa PA, Fasano L, Lavecchia MA, et al. Tuberculin skin test in asymptomatic HIV seropositive carriers. Chest 1989; 96(5):1215-1216.
167. Lein AD, von Reyn CF, Ravn P, et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol 1999; 6(4):606-609.
168. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175(6):618-627.
169. Brock I, Weldingh K, Lillebaek T, et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170(1):65-69.
170. Harada N, Higuchi K, Yoshiyama T, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008; 56(5):348-353.
171. Kim SH, Choi SJ, Kim HB, et al. Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis. Arch Intern Med 2007; 167(20):2255-2259.
172. Soysal A, Torun T, Efe S, et al. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 2008; 12(1): 50-56.
173. Clinicians Guide to Quanti FERON-TB Gold. Melbourne, AUS, Cellestis Ltd. January 13, 2005.
174. Higuchi K, Kawabe Y, Mitarai S, et al. Comparison of performance in two diagnostic methods for tuberculosis infection. Med Microbiol Immunol 2009; 198(1):33-37.
175. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008; 149(3):177-184.
176. Diel R, Loddenkemper R, Meywald-Walter K, et al. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot. TB Test in contact investigations for tuberculosis. Chest 2009; 135(4):1010-1018.
177. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361(9364):1168-1173.
178. Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38(7):966-973.
179. Mazurek GH, Jereb J, LoBue P, et al. Guidelines for using QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection. MMWR Recomm Rep 2005; 54(RR-15):49-55.
180. Health Protection Agency Tuberculosis Programme Board. Health Protection Agency Position Statement on the Use of Interferon Gamma Release Assay (IGRA) Tests for Tuberculosis (TB). February 3, 2009.
181. Diel R, Nienhaus A, Lange C, et al. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J 2006; 28(1):35-44.
182. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. Int J Tuberc Lung Dis 2007; 11(1): 16-26.
183. Lam PK, Lobue PA, Catanzaro A. Clinical diagnosis of tuberculosis by specialists and nonspecialists. Int J Tuberc Lung Dis 2009; 13(5):659-661.
184. Catanzaro A, Lam PK, Bothamley G, et al. Using Clinical Suspicion to Identify Smear-Negative Cases for Culture of Mycobacterium tuberculosis. Kagoshima, Japan: 41st Joint Tuberculosis/Leprosy Conference. 2006.
185. Rao SP, Lam PK, Bothamley G, et al. Integrating laboratory tests and clinical suspicion in tuberculosis (TB) diagnosis. Am J Respir Crit Care Med 2007; 175:A419.